1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Lenvatinib with everolimus for previously treated advanced renal cell carcinoma

Technology appraisal guidance [TA498] Published: 24 January 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 237 KB 16 February 2018  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 389 KB 08 December 2017  
  • Committee papers PDF 1.5 MB 08 December 2017  
  • Public committee slides PDF 502 KB 08 December 2017  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document PDF 394 KB 11 August 2017  
  • Committee papers PDF 7.01 MB 11 August 2017  
  • Public committee slides PDF 1.33 MB 11 August 2017  

Invitation to participate

  • Final scope PDF 224 KB 09 February 2017  
  • Final matrix PDF 258 KB 09 February 2017  
  • NICE's response to comments on the draft scope and provisional matrix PDF 232 KB 09 February 2017  
  • Equality impact assessment (Scoping) PDF 175 KB 09 February 2017